111 related articles for article (PubMed ID: 25400081)
1. Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma.
Kim MJ; Gu MJ; Chang HK; Yu E
Histopathology; 2015 Mar; 66(4):508-16. PubMed ID: 25400081
[TBL] [Abstract][Full Text] [Related]
2. Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.
Lee HJ; Lee OJ; Jang KT; Bae YK; Chung JY; Eom DW; Kim JM; Yu E; Hong SM
Am J Clin Pathol; 2013 Feb; 139(2):167-76. PubMed ID: 23355201
[TBL] [Abstract][Full Text] [Related]
3. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
4. Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma.
Song JS; Yi JM; Cho H; Choi CH; Park Y; Chung EJ; Song J; Chung JY; Hong SM
Tumour Biol; 2018 Oct; 40(10):1010428318808678. PubMed ID: 30375264
[TBL] [Abstract][Full Text] [Related]
5. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract][Full Text] [Related]
6. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
[TBL] [Abstract][Full Text] [Related]
7. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
Liang JW; Wang Z; Zhou ZX; Zhang XM; Hu JJ; Zhao P
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):616-9. PubMed ID: 23158998
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical investigation of tumorigenic pathways in sinonasal intestinal-type adenocarcinoma. A tissue microarray analysis of 62 cases.
Franchi A; Palomba A; Fondi C; Miligi L; Paglierani M; Pepi M; Santucci M
Histopathology; 2011 Jul; 59(1):98-105. PubMed ID: 21668475
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
11. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.
Lam AK; Ong K; Ho YH
Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910
[TBL] [Abstract][Full Text] [Related]
12. ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.
Wiegand KC; Sy K; Kalloger SE; Li-Chang H; Woods R; Kumar A; Streutker CJ; Hafezi-Bakhtiari S; Zhou C; Lim HJ; Huntsman DG; Clarke B; Schaeffer DF
Hum Pathol; 2014 Jun; 45(6):1258-68. PubMed ID: 24767857
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH
World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809
[TBL] [Abstract][Full Text] [Related]
15. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
17. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
Faraj SF; Chaux A; Gonzalez-Roibon N; Munari E; Ellis C; Driscoll T; Schoenberg MP; Bivalacqua TJ; Shih IeM; Netto GJ
Hum Pathol; 2014 Nov; 45(11):2233-9. PubMed ID: 25175170
[TBL] [Abstract][Full Text] [Related]
18. Fascin expression predicts lymph node metastasis and worse survival in small intestinal carcinoma.
Gu MJ; Kim JY; Park JB
Pathology; 2014 Jan; 46(1):21-4. PubMed ID: 24300716
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
Li C; Ji L; Ding ZY; Zhang QD; Huang GR
Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
